Tanshinone generally refers to tanshinone IIA sodium sulfonate injection, this drug can increase coronary blood flow, improve collateral circulation and local blood supply of the myocardium in the ischemic area, improve the metabolic disorders of the hypoxic myocardium, and is used in the adjuvant treatment of coronary artery disease, angina pectoris and myocardial infarction; the side effects are skin rashes, maculopapular rashes and dermatitis.
Tanshinone IIA Sodium Sulfonate Injection is a western medicine, mainly used in coronary heart disease, angina pectoris and myocardial infarction adjuvant therapy. Side effects such as rash, maculopapular rash, dermatitis, anaphylaxis, chills, fever and hypotensive shock may occur in individual patients after using the drug.
It should be noted that this drug should not be used together with drugs such as ambroxol hydrochloride, cimetidine, famotidine, meclofenoxate hydrochloride, magnesium sulfate, clindamycin hydrochloride and quinolone antibiotics. It is contraindicated for those who are allergic to this drug.
Tanshinone IIA Sodium Sulfonate Injection is a prescription medication and needs to be used in accordance with medical advice.